How long has xolair been on the market?

Xolair (omalizumab) was first approved by the U.S. FDA in 2003, so it’s been on the market since 2003—about 23 years as of 2026. It has since received additional indications over the years in various countries. If you want the exact first-approval date for a specific country or indication, tell me which one.